Waleed Kian

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Jair Bar, Nir Peled, Shiruyeh Schokrpur et al. · Journal of Thoracic Oncology · 2022 · 97 citations · Full text

Medicine, Oncology, Pharmacology +14

Real-world experience with capmatinib in <i>MET</i> exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

Oliver Illini, Hannah Fabikan, Aurélie Swalduz et al. · Therapeutic Advances in Medical Oncology · 2022 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases

Iris M. Goldstein, Laila C. Roisman, Shoshana Keren-Rosenberg et al. · Neuro-Oncology Advances · 2020 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

The impact of osimertinib’ line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance

Vered Fuchs, Laila C. Roisman, Waleed Kian et al. · Lung Cancer · 2021 · 26 citations

Medicine, Molecular Biology, Pharmacology +17

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study

Nir Peled, Waleed Kian, Edna Inbar et al. · Neuro-Oncology Advances · 2021 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17